XML 82 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Share Subscription Receivables [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Oct. 31, 2021 $ 55 $ (50,545) $ 4,203,064 $ (102,064) $ 4,050,510
Balance, shares at Oct. 31, 2021 549,140        
Net loss (3,800,392) (3,800,392)
Issuance of common stock for cash, net 40,000 20,000 60,000
Issuance of common stock for cash net, shares 500        
Issuance of founders’ shares 535 8 543
Issuance of founders' shares, shares 4,000        
Issuance of security interest shares to investors $ 22 1,322,911 1,322,933
Issuance of security interest shares to investors, shares 225,000        
Issuance of warrants in connection with investor financing 994,091 994,091
Issuance of restricted stock units to outside directors $ 2 (2)
Issuance of restricted stock units to outside directors, shares 15,000        
Issuance of restricted shares to executives $ 6 (6)
Issuance of restricted stock units to executives, shares 55,000        
Interest imputed on note payable for acquisition of unproved oil and gas properties 89,237 89,237
Stock-based compensation 6,202 6,202
Balance at Oct. 31, 2022 $ 85 (10,010) 6,635,505 (3,902,456) 2,723,124
Balance, shares at Oct. 31, 2022 848,640        
Stock-based compensation $ 2 896,945 896,947
Share-based compensation, shares 21,875        
Net loss (5,224,839) (5,224,839)
Issuance of common stock for services, net   80,160 80,160
Issuance of common stock for services, shares 2,400        
Issuance of common stock upon exercise of warrants, net $ 12   1,812,623 1,812,635
Issuance of common stock upon exercise of warrants, shares 122,474        
Issuance of restricted stock units under the Equity Incentive Plan $ 4   (4)
Issuance of restricted stock units under the Equity Incentive Plan, shares 35,000        
Issuance of common stock for warrants that can be exercised per the Resale S-1/A $ 6   (6)
Issuance of common stock for warrants that can be exercised per the Resale S-1/A, shares 59,993        
Issuance of common stock for cash, net $ 2 371,998 372,000
Issuance of common stock for cash net, shares 20,000        
Issuance of conversion shares related to the SPA $ 25 5,164,850 5,164,875
Issuance of conversion shares related to the SPA, shares 251,946        
Issuance of commitment shares related to the January 2022 SPA $ 2 1,124,998 1,125,000
Issuance of commitment shares related to the SPA, shares 18,750        
Issuance of common shares in IPO, net of underwriting discounts and offering costs $ 10 3,342,616 3,342,626
Issuance of common shares in IPO, net of underwriting discounts and offering costs, shares 100,000        
Issuance of pre-funded warrants 4,000 4,000
Balance at Jul. 31, 2023 $ 148 (10,010) 19,433,685 (9,127,295) 10,296,528
Balance, shares at Jul. 31, 2023 1,481,078        
Balance at Oct. 31, 2022 $ 85 (10,010) 6,635,505 (3,902,456) 2,723,124
Balance, shares at Oct. 31, 2022 848,640        
Issuance of equity warrants in connection with convertible debt (Tranche #1) 332,630 332,630
Stock-based compensation $ 1 1,044,260 1,044,261
Share-based compensation, shares 10,000        
Net loss (6,544,426) (6,544,426)
Issuance of common stock for services, net $ 1 366,658 366,659
Issuance of common stock for services, shares 14,275        
Issuance of conversion shares related to the January 2022 SPA $ 25 5,164,850 5,164,875
Issuance of conversion shares related to the SPA, shares 251,946        
Issuance of common stock upon exercise of warrants, net $ 12 1,812,623 1,812,635
Issuance of common stock upon exercise of warrants, shares 122,474        
Issuance of restricted stock units under the Equity Incentive Plan $ 11 (11)
Issuance of restricted stock units under the Equity Incentive Plan, shares 106,250        
Issuance of common stock for cash, net $ 2 371,998 372,000
Issuance of common stock for cash net, shares 20,000        
Issuance of commitment shares related to the January 2022 SPA $ 2 1,124,998 1,125,000
Issuance of commitment shares related to the SPA, shares 18,750        
Issuance of common shares in IPO, net of underwriting discounts and offering costs $ 10 3,342,616 3,342,626
Issuance of common shares in IPO, net of underwriting discounts and offering costs, shares 100,000        
Issuance of pre-funded warrants 4,000 4,000
Issuance of common stock for warrants that can be exercised per the Resale S-1/A 6 (6)
Issuance of common stock for warrants that can be exercised per the Resale S-1/A, shares 59,993        
Balance at Oct. 31, 2023 $ 155 (10,010) 20,200,121 (10,446,882) 9,743,384
Balance, shares at Oct. 31, 2023 1,552,328        
Balance at Apr. 30, 2023 $ 124 (10,010) 16,754,953 (6,956,694) 9,788,373
Balance, shares at Apr. 30, 2023 1,239,961        
Stock-based compensation $ 2 785,960 785,962
Share-based compensation, shares 21,250        
Net loss (2,170,601) (2,170,601)
Issuance of common stock for services, net 80,159 80,159
Issuance of common stock for services, shares 2,400        
Issuance of common stock upon exercise of warrants, net $ 12 1,812,623 1,812,635
Issuance of common stock upon exercise of warrants, shares 122,474        
Issuance of restricted stock units under the Equity Incentive Plan $ 4 (4)
Issuance of restricted stock units under the Equity Incentive Plan, shares 35,000        
Issuance of common stock for warrants that can be exercised per the Resale S-1/A $ 6 (6)
Issuance of common stock for warrants that can be exercised per the Resale S-1/A, shares 59,993        
Balance at Jul. 31, 2023 $ 148 (10,010) 19,433,685 (9,127,295) 10,296,528
Balance, shares at Jul. 31, 2023 1,481,078        
Balance at Oct. 31, 2023 $ 155 (10,010) 20,200,121 (10,446,882) 9,743,384
Balance, shares at Oct. 31, 2023 1,552,328        
Issuance of equity warrants in connection with convertible debt (Tranche #1) 409,191 409,191
Stock-based compensation 1,150,852 1,150,852
Net loss (7,926,554) (7,926,554)
Issuance of common stock for services, net $ 10 694,490 694,500
Issuance of common stock for services, shares 95,000        
Issuance of conversion shares related to the January 2022 SPA $ 82 3,323,505   3,323,587
Issuance of conversion shares related to the SPA, shares 816,681        
Issuance of commitment shares in connection with the April 2024 Financings $ 8 667,492 667,500
Issuance of commitment shares in connection with the April 2024 Financings, shares 75,000        
Adjustment related to Resale S-1/A warrants [1] $ 3 3
Adjustment related to Resale S-1/A warrants, shares [1] 22,590        
Balance at Jul. 31, 2024 $ 252 (10,010) 26,445,654 (18,373,436) 8,062,460
Balance, shares at Jul. 31, 2024 2,516,419        
Balance at Apr. 30, 2024 $ 252 (10,010) 25,949,631 (16,194,865) 9,745,008
Balance, shares at Apr. 30, 2024 2,516,419        
Issuance of equity warrants in connection with convertible debt (Tranche #1) 257,701 257,701
Stock-based compensation 238,322 238,322
Share-based compensation, shares        
Net loss (2,178,571) (2,178,571)
Balance at Jul. 31, 2024 $ 252 $ (10,010) $ 26,445,654 $ (18,373,436) $ 8,062,460
Balance, shares at Jul. 31, 2024 2,516,419        
[1] Amount is for an adjustment for shares recorded as not exercised but registered in accordance with their warrant agreements.